Clinical Trials Browser

Interventional × bemarituzumab × Thoracic × Clear all

Adenocarcinoma of Lung, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Ovarian Epithelial, Uterine Cervical Neoplasms, Cholangiocarcinoma, Triple Negative Breast Neoplasms

NCT05267470 2025-03-25

FORTITUDE-201

Phase 1 Terminated

74 enrolled 22 charts

Thoracic

Squamous-Cell Non-Small-Cell Lung Cancer

Clinical Trials

FORTITUDE-301

FORTITUDE-201